That's right, this morning was a three-hour, 45-minute, no-break marathon on everything you wanted to know about commercial support, but never had the opportunity to ask. Led by moderator Lawrence Sherman, who I just learned today has left Jobson...
I've been told that I can't write anything about this session without running it past the American Medical Association first, but from what I heard, most of the updates to the system have to do with protecting the AMA's intellectual property and...
This turned out to be a really interesting session. Brooke Johnson, Duke Office of Continuing Medical Education, walked us through a pilot study she conducted to determine what physicians, residents, and pharmacists know about what's appropriate...
I missed some of the beginning stuff in this session, like the definition of speakers bureau and the regulations that affect speakers bureaus (I came in just as Debra Gist, consultant, was finishing up on the regs part and was recommending that...
This free-for-all, no-holds-barred CME provider/industry dialogue, led by Maureen Doyle-Scharff of Abbott Laboratories and Mike Saxton with Wyeth Pharmaceuticals was pretty lively, to say the least. It was pretty much all a back-and-forth between...
I just got an e-mail from someone with a question I can't answer about California Senate Bill 1765. Does this legislation apply to medical conventions held outside of the state of California where California healthcare professionals attend, or is...
I missed the beginning of this one, but what I experienced of the rest was terrific. Led by Carol Havens, MD, and Philip Bellman, MPH, both with Kaiser Permanente Northern California, they went through why good outcomes begin with good needs...